Incyte to Report Second Quarter 2014 Financial Results on July 31
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, July 31, 2014. The schedule for the press release and conference call is as follows:
- Q2 2014 Press Release: July 31, 2014 at 7:00 a.m. ET
- Q2 2014 Conference Call: July 31, 2014 at 8:30 a.m. ET
- Domestic Dial In Number: 877-407-8037
- International Dial In Number: 201-689-8037
- Conference ID # 13586309
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13586309.
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.